文献速递主动脉疾病

晚期食管癌患者预防性胸主动脉腔内修复术的初步经验

Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer.
PubMed 文献 · Ann Vasc Surg · 2019-08-05

本研究报道2016至2018年间3例晚期食管癌累及胸主动脉患者接受预防性TEVAR的初步经验,所有手术顺利,术后患者均重新符合放化疗条件。

要点

  • 晚期食管癌累及主动脉壁常禁忌放化疗,预防性TEVAR可覆盖主动脉腔。
  • 3例预防性TEVAR手术均顺利,无不良事件。
  • 术后所有患者均重新评估为适合术前或根治性放化疗。

核心结论

  • 预防性TEVAR在晚期食管癌累及胸主动脉患者中可行,可使患者重新获得放化疗机会。

研究设计与样本

  • 2016至2018年间单中心 tertiary hospital 的3例晚期食管癌累及胸主动脉患者接受预防性TEVAR的初步经验。

主要发现

  • 所有预防性TEVAR手术均顺利(uneventful)。
  • 所有患者术后均重新评估为适合术前或根治性放化疗。

临床怎么用

  • 对晚期食管癌累及胸主动脉且因主动脉壁受累而禁忌放化疗的患者,可考虑预防性TEVAR以覆盖主动脉腔,为后续放化疗创造条件。

局限性

  • 样本量仅3例,为初步经验,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bleeding from the thoracic aorta is potentially fatal in patients with advanced esophageal cancer (AEC). Esophageal malignancy is the third most common cause of aortoesophageal fistula, after thoracic aortic aneurysm and ingestion of foreign body. The involvement of aortic wall often contraindicates chemoradiotherapy (CRT) treatment, thus reducing life expectancy of these patients. Thoracic endovascular aortic repair (TEVAR) is a well-described mini-invasive technique that can be also applied for coverage of the aortic lumen in case of invasion by esophageal cancer. Only few cases have been published with this atypical indication. Between 2016 and 2018, in our tertiary hospital 3 patients affected by AEC involving the thoracic aorta were treated by means of prophylactic TEVAR. All procedures were uneventful, and all patients were reconsidered fit for preoperative or definitive CRT.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mezzetto L, Scorsone L, De Pasqual CA, et al. Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer. Ann Vasc Surg. 2019. PMID: 31394222. doi:10.1016/j.avsg.2019.05.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。